|
 |
Ibandronic AcidThis page contains recent news articles, when available, and an overview of Ibandronic Acid but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.At Roche's Full Year Results Meeting, 2 February 2005, London, UK, it was announced that, following approval, a once-monthly oral formulation of ibandronic ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Scottish Medicines Consortium Approves Bonviva(R) - Scottish Women … - Feb 14, 2006 The exact SMC advice is: Ibandronic acid (Bonviva) is accepted for use ... Ibandronic acid 150mg monthly is superior to daily ibandronic acid in terms of ... Medical News Today - Medical News Today (press release) ibandronic acid Roche, GlaxoSmithKline supplemental approval, USA ( … - Apr 4, 2005 Ibandronic acid, a third-generation bisphosphonate, is available in several ... ibandronic acid, ibandronate sodium, BM 210955, R 484, BONDRONAT, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones ibandronic acid Chugai provides development update. - Nov 21, 2005 On 20 October 2005 Chugai reported that it has initiated phase II trials of an oral formulation of ibandronic acid, in Japan, for the treatment of ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones A press release distributed by PR Newswire Europe - Sep 20, 2005 Bonviva (ibandronic acid) is an effective bisphosphonate treatment for ... Patients should take once-monthly ibandronic acid with plain water on an empty ... prnewswire.co.uk FAES to launch second ibandronate brand.(marketing agreement with … - Jun 25, 2007 Last month, Roche and GSK launched Bonviva 3mg (ibandronic acid) IV in the UK as a quarterly pre-filled injection (Marketletter May 8). Free with registration - Pharma Marketletter - AccessMyLibrary.com EMEA - Committee For Medicinal Products For Human Use - 23-26 … - Jan 23, 2006 The CHMP also recommended the approval of Bondenza (ibandronic acid) and Bonviva (ibandronic acid) 3mg/3ml solution for injection. Bondenza and Bonviva were ... Medical News Today - Medical News Today (press release) New data show Bondronat(R) prevents bone Loss caused by anastrozole … - May 6, 2007 Chicago- Bondronat(R) (ibandronic acid) has been shown to prevent bone loss caused ... About Bondronat(R) (ibandronic acid) - Bondronat was approved by the ... Revista Fator OnMedica - News: European marketing authorisation has been granted … - Apr 5, 2006 European marketing authorisation has been granted for quarterly intravenous (IV) injection of the osteoporosis medication Bonviva (ibandronic acid). ... OnMedica 'Filipinizing' osteoporosis - Sep 5, 2006 At the Roche Bone Health and Wellness Center, osteoporosis patients, especially those prescribed ibandronic acid, can undergo free bone density tests with ... Pay-Per-View - Philippine Daily Inquirer - Factiva, from Dow Jones Osteoporosis; Once-monthly tablet for women with postmenopausal … - Oct 24, 2005 2005 OCT 24 - (NewsRx.com) -- The first once-monthly tablet for any chronic condition was launched in the UK Bonviva (ibandronic acid) is an effective ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones Roche/GSK launches Bonviva.(intravenous bisphosphonate injection)( … - May 8, 2006 Bonviva 3mg (ibandronic acid) IV has been approved in the UK as a quarterly ... For those women who cannot take oral medications, the ibandronic acid IV ... $4.95 - Pharma Marketletter - ECNext Osteoporosis; Once-monthly tablet for women with postmenopausal … - Oct 25, 2005 2005 OCT 25 - (NewsRx.com) -- The first once-monthly tablet for any chronic condition was launched in the UK Bonviva (ibandronic acid) is an effective ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Roche/GSK launches Bonviva - Apr 28, 2006 Bonviva 3mg (ibandronic acid) IV has been approved in the UK as a quarterly ... For those women who cannot take oral medications, the ibandronic acid IV ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Extraction venue - Jan 12, 2008 In the ibandronic acid, pamidronate and zoledronic acid cases a high incidence and severity of BONJ is accepted. Most specialist units would I am sure be ... Nature.com Osteoporosis; Once-monthly tablet for women with postmenopausal … - Oct 29, 2005 2005 OCT 29 - (NewsRx.com) -- The first once-monthly tablet for any chronic condition was launched in the UK Bonviva (ibandronic acid) is an effective ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Scriptlines: Bonviva IV - Apr 22, 2006 Bonviva 3mg injection (ibandronic acid) has become the first intravenous ... This showed that intravenous ibandronic acid was effective and well tolerated ... Pay-Per-View - Chemist & Druggist - Factiva, from Dow Jones New Data Show Bondronat(R) Prevents Bone Loss Caused by … - Jun 4, 2007 Bondronat(R) (ibandronic acid) has been shown to prevent bone loss caused by anastrozole in post-menopausal women given adjuvant therapy for early breast ... ANTARA Press Release: Launch of First Once-Monthly Tablet Aims to Offer More... - Sep 20, 2005 Bonviva (ibandronic acid) is an effective bisphosphonate treatment for postmenopausal osteoporosis which helps to rebuild bone, making bones less likely to ... Pay-Per-View - PR Newswire Europe - HighBeam Research Potential new drug targets for osteoporosis - May 6, 2008 Nitrogen-containing bisphosphonates—such as risedronate sodium, zoledronic acid, disodium pamidronate, alendronic acid and ibandronic acid—work ... Nature.com Faes Farma signs agreement with Roche, GlaxoSmithKline for … - Jun 15, 2007 MADRID (Thomson Financial) - Faes Farma SA said it has signed an agreement with Roche Holdings AG and GlaxoSmithKline PLC to market a new ibandronic acid ... Forbes Bisphosphonate induced osteochemonecrosis of the jaw mimicking a … - Jul 28, 2007 The patient recommenced oral therapy in the form of Ibandronic acid in August 2004. She stopped her bisphosphonate therapy after her oral diagnosis was made ... Nature.com Assessment of fracture risk key in osteoporosis. - Dec 19, 2008 ...patients taking oral glucocorticoids, and does not include newer interventions such as ibandronic acid and zoledronic acid. ... $9.94 - The Practitioner - Alacra Store Elder Pharma to market Roche drug - Dec 15, 2006 Bonviva, whose main active ingredient is ibandronic acid, is priced at Rs 2500 a tablet and has a dosage regimen of one tablet a month. ... Hindu Business Line Oral osteoporosis medications 'do not cause jaw bone death' - Jan 4, 2008 In 2007, reports emerged that bisphosphonate (bone-building) drugs like alendronate, risedronate sodium and ibandronic acid could cause people with ... Arthritis Research Campaign BONE DRUG GREEN LIGHT - Feb 15, 2006 The drug, also known as ibandronic acid, was approved by the Scottish Medicine Consortium yesterday. Osteoporosis means "porous bones" and occurs when the ... Scottish Daily Record Briefly Series: BUSINESS DIGEST - Mar 14, 2005 20-22 in Miami about a study to evaluate the effectiveness of ibandronic acid vs. zoledroni acid for patients with cancer that has spread to the bones. ... Pay-Per-View - St. Petersburg Times - ProQuest Archiver New Data Show Bondronat(R) Prevents Bone Loss Caused by … - Feb 6, 2007 Bondronat(R) (ibandronic acid) has been shown to prevent bone loss caused by anastrozole in post-menopausal women given adjuvant therapy for early breast ... presseportal.de Help make dying mum Angela's final wish come true - Aug 14, 2008 She is also taking part in a trial of the drug ibandronic acid to help strengthen her bones. She said: "Anything they can do for me will prolong my life ... Shields Gazette Elder to market Roche's drug - Jan 15, 2007 Launched in 2005 in USA and Europe, Bonviva whose main active ingredient is ibandronic acid, belongs to a class of drugs called bisphosphonates. ... Express Pharma Tamiflu and weak dollar impact Roche sales but cancer drug turnover … - Apr 28, 2008 A strong performance was reported for osteoporosis drug Bonviva/Boniva (ibandronic acid). However, turnover from the firm's weight-loss drug Xenical ... $9.94 - Pharma Marketletter - Alacra Store Ask the Doctor: First step to bone health is awareness - Mar 14, 2007 Ibandronic acid (Boniva), raloxifene (Evista) and estrogen also protect the spine, but show only a small effect on the hip and other areas. ... Terre Haute Tribune Star Pharmacy update: Battling breaking bones.(Preventing and treating … - May 20, 2006 ...women aged over 70 years, with bisphosphonates (eg, alendronic acid, risedronate sodium, disodium etidronate, ibandronic acid) the treatment of choice. ... Free with registration - Chemist & Druggist - AccessMyLibrary.com UK policy: English doctors face sack over non-NICE RXing - Dec 16, 2008 ...after [an ischemic heart disease event] instead of simvastatin or Bonviva [ibandronic acid] instead of etidronate for prevention of OP [osteoporosis]." ... $34.00 - EIU Country Analysis - Alacra Store The silent bone destroyer . - Aug 15, 2006 Among the latest medical products in the market for the management of the disease are oral (once-monthly ibandronic acid) that have been found to ... Philippine Daily Inquirer - Google News Archive Women with postmenopausal osteoporosis prefer once monthly to weekly … - Sep 26, 2005 Patient preference for once-monthly oral bisphosphonate Bonviva 150mg (ibandronic acid) was clearly demonstrated in results from the BALTO study (Bonviva ... News-Medical.net Letter: VOICE OF THE NORTH - Real heroes 'are being overlooked'.( … - Oct 2, 2008 Bonviva ( ibandronic acid ( is used to treat post-menopausal osteoporosis by helping to rebuild bone. Current treatments for the condition, which affects an ... Pay-Per-View - The Journal - HighBeam Research Roche pleases investors with 15% hike in first-half sales and strong ... - Jul 30, 2007 Among metabolic disease drugs, Bonviva/Boniva (ibandronic acid), available as a once-monthly tablet and three-monthly injection for the treatment of ... $9.94 - Pharma Marketletter - Alacra Store FDA approves first quarterly IV injection for postmenopausal osteoporo... - Jan 9, 2006 ...quarterly intravenous (IV) injection of the potent and highly effective osteoporosis drug Boniva (ibandronic acid). This is the first ever IV injection ... biotech-intelligence.com Roche/GSK's Bonviva approved in Switzerland.(Brief Article) - Sep 19, 2005 Swiss drugmaker Roche and UK drug major GlaxoSmithKline's co-developed drug Bonviva (ibandronic acid) has been approved by the Swiss health authority ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones European positive opinion for first quarterly IV injection for … - Jan 27, 2006 ...medication Bonviva® (ibandronic acid) has been recommended for approval in the EU by the Committee for Medicinal Products for Human Use (CHMP). ... webwire.com Chugai Announces Co-Development and Co-Marketing Agreement with … - Sep 12, 2006 ...and co-market R484 (generic name: ibandronic acid), a bisphosphonate which Chugai is currently developing in Japan for the treatment of osteoporosis. ... Free with registration - JCN Newswires - AccessMyLibrary.com GSK and Roche present Bonviva trial data.(GlaxoSmithKline PLC, Roche ... - Oct 3, 2005 Over 70 % of postmenopausal women with osteoporosis prefered once-monthly Bonviva (ibandronic acid), an osteoporosis therapy which has been co-developed ... $4.95 - Pharma Marketletter - ECNext Roche Osteoporosis Drug Bonviva to be Marketed by Elder … - Dec 14, 2006 Launched in 2005 in USA and Europe, Bonviva - whose main active ingredient is ibandronic acid - belongs to a class of drugs called bisphosphonates and has a ... Equity Bulls Japan stock market week to June 27. - Jul 4, 2005 Chugai edged down 0.7%, despite a positive report on Bonviva (ibandronic acid), a treatment for osteoporosis. Roche and GlaxoSmithKline have unveiled new ... $4.95 - Pharma Marketletter - ECNext Women With Osteoporosis More Likely To Stay On Once-Monthly Oral … - Sep 18, 2006 Women taking highly effective once-monthly oral Bonviva(R) (ibandronic acid) for postmenopausal osteoporosis were more likely to stay on treatment during ... Medical News Today - Medical News Today (press release) Once-Monthly Bonviva(R), An Important Advance In The Treatment Of … - May 17, 2006 ...that the only once-monthly bisphosphonate, Bonviva(R) (ibandronic acid), is proving to be an important step forwards in the treatment of osteoporosis. ... Medical News Today - Medical News Today (press release) EU approves Roche/GSK's Bonviva IV.(F. Hoffmann-La Roche Ltd.)( … - Apr 3, 2006 ...have received European marketing authorization for their quarterly intravenous injectible osteoporosis medication, Bonviva (ibandronic acid). ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Summary and Introduction - Aug 25, 2006 The once-monthly oral formulation of the bisphosphonate ibandronate (also known as ibandronic acid) has been shown to be as effective and well-tolerated as ... Medscape February's Big Freeze Threatens To Hit Elderly Hardest - Mar 3, 2006 In December 2001, Roche and GSK announced that they would co-develop and co-promote ibandronic acid for the treatment of postmenopausal osteoporosis in all ... Medical News Today - Medical News Today (press release) European Positive Opinion For First Quarterly IV Injection For … - Jan 30, 2006 ...medication BonvivaÆ (ibandronic acid) has been recommended for approval in the EU by the Committee for Medicinal Products for Human Use (CHMP). ... Medical News Today - Medical News Today (press release) Once-monthly biphosphonate released - Jul 20, 2006 The biphosphonate drug, ibandronic acid, was approved by the Therapeutic Goods Administration last month for the treatment of postmenopausal osteoporosis. ... Pharmacy News Bonviva injection set for EU approval.(GlaxoSmithKline PLC)(F.... - Feb 6, 2006 ...and UK-based giant GlaxoSmithKline say that a new four-times a year intravenous injection of the osteoperosis medication Bonviva (ibandronic acid), ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Elder Pharmaceuticals ties up with Roche to market Bonviva in India - Dec 21, 2006 Launched in 2005 in USA and Europe, Bonviva - whose main active ingredient is ibandronic acid - belongs to a class of drugs called bisphosphonates and has a ... pharmabiz.com Chugai and Taisho to Co-Develop and Market Antiresorptive … - Sep 13, 2006 ...to co-develop and market antiresorptive bisphosphonate R484, (generic name: ibandronic acid) for treatment of osteoporosis in post-menopausal women. ... Free with registration - JCNN News Summaries - AccessMyLibrary.com EMEA suggests wider drug use.(European Medicines Evalution Agency)( … - Feb 4, 2006 Bonviva and Bondenza (ibandronic acid) - suggested approval for intravenous administration once every three months for the treatment of osteoporosis. ... Free with registration - Chemist & Druggist - AccessMyLibrary.com Osteoporosis: the "silent epidemic . - Jul 8, 2006 According to Dr. Gamilla, patients taking boneprotecting medicines like ibandronic acid should be able to sus tain treatment for the re quired period (one ... Philippine Daily Inquirer - Google News Archive Chugai and Taisho to Co-Develop and Market Antiresorptive … - Sep 13, 2006 ...to co-develop and market antiresorptive bisphosphonate R484, (generic name: ibandronic acid) for treatment of osteoporosis in post-menopausal women. ... japancorp.net Once a month would be enough for pharmacists. - Oct 1, 2005 I imagine this dosage schedule is only possible because of the pharmacodynamics of ibandronic acid, but if a sustained release formulation made it possible ... $9.94 - Chemist & Druggist - Alacra Store Stock Commentary - Europe.(Brief Article) - Jul 4, 2005 ...respectively, and despite the latter getting positive European approval news for its Bonviva (ibandronic acid) and Tarceva (erlotinib; see page 22). ... $4.95 - Pharma Marketletter - ECNext US FDA approves Roche/GSK's Bonviva IV - Mar 31, 2006 ...have received European marketing authorization for their quarterly intravenous injectible osteoporosis medication, Bonviva (ibandronic acid). ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Press Release: New Bone Biopsy Study Confirms Unique Dual Mode of … - Sep 23, 2005 ...which helps to rebuild bone, making bones ... promote ibandronic acid for the treatment of postmenopausal osteoporosis in all countries, except Japan. ... Pay-Per-View - PR Newswire Europe - HighBeam Research Positive EU opinion for Roche/GSK's Bonviva.(Brief Article) - Jul 4, 2005 Swiss drug major Roche and UK-based GlaxoSmithKline's Bonviva (ibandronic acid) has received a positive opinion from the European Committee for Medicinal ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones New treatment.(News) | Article from Daily Post (Liverpool, England) |... - Sep 21, 2005 Bonviva - ibandronic acid - is used to treat postmenopausal osteoporosis by helping to rebuild bone and making them less likely to break. ... Pay-Per-View - Daily Post - HighBeam Research Boon for brittle bones.(News) | Article from The Journal (Newcastle, ... - Sep 21, 2005 Bonviva ( ibandronic acid ( is u... ... Bonviva ( ibandronic acid ( is used to treat post-menopausal osteoporosis by helping to rebuild bone. ... Pay-Per-View - The Journal - HighBeam Research Stock Commentary - Europe - week to Sept 12.(Brief Article) - Sep 19, 2005 ...rising 5.1%, while Roche gained 3.8%, boosted by the Swiss approval of its once-daily osteoporosis drug Bonviva (ibandronic acid; see page 23). ... $4.95 - Pharma Marketletter - ECNext Japan stock market week to Sept 18, 2006. - Sep 25, 2006 Chugai gained 2.6% due to its announcement that it has agreed with Taisho to co-develop and co-market R484 (ibandronic acid), a bisphosphonate for the ... $9.94 - Pharma Marketletter - Alacra Store Down to the bone: Prevention and treatment of osteoporosis — a home … - Nov 23, 2006 A monthly oral medication, Bonviva Once Monthly (ibandronic acid), has recently been approved in Australia and may offer even greater improvement with ... Pay-Per-View - Pharmacy News - Factiva, from Dow Jones New drugs in the pipeline: Chugai. [1 table in original article] - Dec 4, 2006 Phase III trials are also being carried out on: ED-71 for the treatment of osteoporosis; ibandronic acid for the treatment of osteoporosis; and CHS13340 ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Boon for brittle bones.(News) | Article from Daily Record (Glasgow, … - Feb 15, 2006 The drug, also known as ibandronic acid, was approved by the Scottish Medicine Consortium. Read all of this article with a FREE trial ... Pay-Per-View - Daily Record - HighBeam Research Scriptlines: Bonviva tabs. - Sep 24, 2005 The recommended dosing of the ibandronic acid product is one film- coated tablet on the same date each month, after an overnight fast and one hour before ... $4.95 - Chemist & Druggist - ECNext REGULATORY NEWS IN BRIEF - Oct 10, 2005 ...obtained marketing authorization in Europe for the postmenopausal osteoporosis treatment Bonviva 150 mg (ibandronic acid) on September 19. ... Pay-Per-View - Pharma Japan - Factiva, from Dow Jones Japan stock market week to Oct 10. - Oct 17, 2005 Union marketing authorization approval for once-monthly oral Bonviva (ibandronic acid) for postmenopausal osteoporosis (Marketletter September 25). ... $4.95 - Pharma Marketletter - ECNext MediaWatch: `New osteoporosis pill' - Oct 1, 2005 Drug companies Roche and GlaxoSmithKline jointly launched Bonviva (ibandronic acid), a new bisphosphonate and the first to be taken monthly. ... Pay-Per-View - Pulse - Factiva, from Dow Jones OTC: New prescription products - Bonviva.(Roche Products Ltd.)(Brief ... - Dec 3, 2005 Tablets containing ibandronic acid 150mg. Usual dose: one tablet on the same date each month, after an overnight fast and one hour before the first food, ... $4.95 - Chemist & Druggist - ECNext Factiva Search - Jun 20, 2005 ...ibandronic acid Roche clinical data (osteoporosis).(Brief Article). 20 June, 2005 R & D Focus Drug News. On 9 June 2005 GlaxoSmithKline and Roche reported ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Factiva Search - Mar 28, 2005 ...ibandronic acid Roche clinical data. 28 March, 2005 R & D Focus Drug News. At the 5th European Congress on Clinical and Economic Aspects of Osteoporosis and ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Trial subjects favor once-daily Bonviva.(GlaxoSmithKline PLC's … - Mar 27, 2006 Subjects were provided with both a monthly dose of the drug Boniva (ibandronic acid), which the firm co-developed with Roche, and a once-weekly dose of ... $4.95 - Pharma Marketletter - ECNext ::: ê±´ê°•ì?´ ë³´ì?´ëŠ” ëŒ€í•œë¯¼êµ ëŒ€í‘œ ì?˜ë£Œì‹ 문 메디컬투ë?°ì?´ ::: - May 18, 2006 ...ì œìž¬ì?¸ 본비바(Bonviva:ibandronic acid)ê°€ 골성장ì?˜ 효과가 있다는 ì¦?ê±°ê°€ ì œì‹œ ë?˜ë©´ì„œ 골다공ì¦?ì?„ 치료하는ë?° 있어서 íš?기ì ?ì?¸ 치료ë?¼ëŠ” í?‰ê°€ê°€ 있었다. ... 메디컬투ë?°ì?´ |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
